Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Epygenix Submits IND Application for EPX-100 for Dravet Syndrome

americanpharmaceuticalreviewJune 26, 2019

Tag: IND , Dravet syndrome , Epygenix

PharmaSources Customer Service